Literature DB >> 26026282

MicroRNA: Key regulators of oligodendrocyte development and pathobiology.

John-Mark K Fitzpatrick1, Rebecca C Anderson1, Kieran W McDermott2.   

Abstract

MicroRNAs (miRNAs or miRs) are a group of small non-coding RNAs that function through binding to messenger RNA (mRNA) targets and downregulating gene expression. miRNAs have been shown to regulate many cellular functions including proliferation, differentiation, development and apoptosis. Recently, evidence has grown which shows the involvement of miRs in oligodendrocyte (OL) specification and development. In particular, miRs-138, -219, -338, and -9 have been classified as key regulators of OL development, acting at various points in the OL lineage and influencing precursor cell transit into mature myelinating OLs. Many studies have emerged which link miRNAs with OL and myelin pathology in various central nervous system (CNS) diseases including multiple sclerosis (MS), ischemic stroke, spinal cord injury, and adult-onset autosomal dominant leukodystrophy (ADLD).
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CNS; Development; MicroRNA; Myelination; Oligodendrocyte

Mesh:

Substances:

Year:  2015        PMID: 26026282     DOI: 10.1016/j.biocel.2015.05.021

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  12 in total

1.  Role of Transcription Factor Nrf2 in Pyroptosis in Spinal Cord Injury by Regulating GSDMD.

Authors:  Dehua Zhang; Feng Mao; Shaobo Wang; Hongzi Wu; Shun Wang; Yi Liao
Journal:  Neurochem Res       Date:  2022-08-30       Impact factor: 4.414

2.  Association of MicroRNAs With Risk of Stroke: A Meta-Analysis.

Authors:  Yidong Deng; Peijian Huang; Fan Zhang; Tao Chen
Journal:  Front Neurol       Date:  2022-05-19       Impact factor: 4.086

Review 3.  The Molecular Mechanisms Through Which Placental Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Myelin Regeneration.

Authors:  Kaitlin C Clark; David Wang; Priyadarsini Kumar; Sirjan Mor; Edwin Kulubya; Sabrina V Lazar; Aijun Wang
Journal:  Adv Biol (Weinh)       Date:  2022-01-13

4.  MicroRNA-21: Expression in oligodendrocytes and correlation with low myelin mRNAs in depression and alcoholism.

Authors:  José Javier Miguel-Hidalgo; Katherine O Hall; Hannah Bonner; Anna M Roller; Maryam Syed; Casey J Park; Jana P Ball; Marc E Rothenberg; Craig A Stockmeier; Damian G Romero
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-08-09       Impact factor: 5.067

5.  Extracellular Vesicles from Vascular Endothelial Cells Promote Survival, Proliferation and Motility of Oligodendrocyte Precursor Cells.

Authors:  Masashi Kurachi; Masahiko Mikuni; Yasuki Ishizaki
Journal:  PLoS One       Date:  2016-07-12       Impact factor: 3.240

Review 6.  Extrinsic and Intrinsic Regulation of Axon Regeneration by MicroRNAs after Spinal Cord Injury.

Authors:  Ping Li; Zhao-Qian Teng; Chang-Mei Liu
Journal:  Neural Plast       Date:  2016-10-13       Impact factor: 3.599

7.  Systemic functional enrichment and ceRNA network identification following peripheral nerve injury.

Authors:  Tianmei Qian; Chunlin Fan; Qianyan Liu; Sheng Yi
Journal:  Mol Brain       Date:  2018-12-17       Impact factor: 4.041

8.  MicroRNA-219 Inhibits Proliferation and Induces Differentiation of Oligodendrocyte Precursor Cells after Contusion Spinal Cord Injury in Rats.

Authors:  Fang Li; Mou-Wang Zhou; Nan Liu; Yan-Yan Yang; Hua-Yi Xing; Yao Lu; Xiao-Xie Liu
Journal:  Neural Plast       Date:  2019-02-18       Impact factor: 3.599

Review 9.  From OPC to Oligodendrocyte: An Epigenetic Journey.

Authors:  Assia Tiane; Melissa Schepers; Ben Rombaut; Raymond Hupperts; Jos Prickaerts; Niels Hellings; Daniel van den Hove; Tim Vanmierlo
Journal:  Cells       Date:  2019-10-11       Impact factor: 6.600

Review 10.  Molecular Neuropathology of Astrocytes and Oligodendrocytes in Alcohol Use Disorders.

Authors:  José J Miguel-Hidalgo
Journal:  Front Mol Neurosci       Date:  2018-03-20       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.